Gastrocrom Alternatives Compared
Gastrocrom | Rowasa | Budesonide |
|
---|
Gastrocrom (cromolyn) | Rowasa (mesalamine) | Budesonide |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Systemic Mastocytosis, Inflammatory Bowel Disease. Gastrocrom may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Inflammatory Bowel Disease, Ulcerative Proctitis, Ulcerative Colitis - Maintenance, Ulcerative Colitis - Active, Ulcerative Colitis. Rowasa may also be used for purposes not listed in... View more |
Prescription only
Prescribed for Crohn's Disease, Asthma - Maintenance, Crohn's Disease - Acute, IgA Nephropathy, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis - Active, Ulcerative... View more |
Related suggestions Inflammatory Bowel Disease
Popular comparisons
|
|||||||||||||||||||||||
More about Gastrocrom (cromolyn) | More about Rowasa (mesalamine) | More about Budesonide | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Gastrocrom has an average rating of 6.7 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
Rowasa has an average rating of 7.6 out of 10 from a total of 8 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 13% reported a negative effect. |
Budesonide has an average rating of 6.6 out of 10 from a total of 131 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Gastrocrom side effects in more detail. |
See also: Rowasa side effects in more detail. |
Commonly reported side effects include:
See also: budesonide side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Gastrocrom prices and generic prices |
View all Rowasa prices and generic prices |
View all budesonide prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Other mesalamine brands include: Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Pentasa, Rowasa Sulfite Free, Zaldyon View more | Entocort EC, Ortikos, Pulmicort Flexhaler, Pulmicort Respules, Tarpeyo, Uceris | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
3 hours |
10 hours |
2.8 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 1 drugs are known to interact with Gastrocrom:
|
A total of 115 drugs are known to interact with Rowasa:
|
A total of 471 drugs are known to interact with budesonide:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
December 24, 1987 |
October 02, 2001 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.